金年会|金年会·jinnian(金字招牌)诚信至上

Novodine ® Desloratadine dry suspension

In 2016, 2019, 2020 and 2021, it was listed in the "China Pharmaceutical-Brand List" for four consecutive times; It was also listed as "Chinese family medicine". It has been approved for listing in the Netherlands and Germany, and has passed the consistency evaluation. Allergic diseases have become one of the most common global diseases in the 21st century. At present, the total prevalence of global allergies has reached 22%, and hundreds of millions of patients are suffering from allergies.

Fuyuan ® Desloratadine dry suspension

In 2016, 2019, 2020 and 2021, it was listed in the "China Pharmaceutical-Brand List" for four consecutive times; It was also listed as "Chinese family medicine". It has been approved for listing in the Netherlands and Germany, and has passed the consistency evaluation. Allergic diseases have become one of the most common global diseases in the 21st century. At present, the total prevalence of global allergies has reached 22%, and hundreds of millions of patients are suffering from allergies.

Easy access ® Desloratadine dry suspension

In 2016, 2019, 2020 and 2021, it was listed in the "China Pharmaceutical-Brand List" for four consecutive times; It was also listed as "Chinese family medicine". It has been approved for listing in the Netherlands and Germany, and has passed the consistency evaluation. Allergic diseases have become one of the most common global diseases in the 21st century. At present, the total prevalence of global allergies has reached 22%, and hundreds of millions of patients are suffering from allergies.

Promise ® Desloratadine dry suspension

In 2016, 2019, 2020 and 2021, it was listed in the "China Pharmaceutical-Brand List" for four consecutive times; It was also listed as "Chinese family medicine". It has been approved for listing in the Netherlands and Germany, and has passed the consistency evaluation. Allergic diseases have become one of the most common global diseases in the 21st century. At present, the total prevalence of global allergies has reached 22%, and hundreds of millions of patients are suffering from allergies.

Fubiding ® Desloratadine dry suspension2

In 2016, 2019, 2020 and 2021, it was listed in the "China Pharmaceutical-Brand List" for four consecutive times; It was also listed as "Chinese family medicine". It has been approved for listing in the Netherlands and Germany, and has passed the consistency evaluation. Allergic diseases have become one of the most common global diseases in the 21st century. At present, the total prevalence of global allergies has reached 22%, and hundreds of millions of patients are suffering from allergies.

Fubiding ® Desloratadine dry suspension

In 2016, 2019, 2020 and 2021, it was listed in the "China Pharmaceutical-Brand List" for four consecutive times; It was also listed as "Chinese family medicine". It has been approved for listing in the Netherlands and Germany, and has passed the consistency evaluation. Allergic diseases have become one of the most common global diseases in the 21st century. At present, the total prevalence of global allergies has reached 22%, and hundreds of millions of patients are suffering from allergies.